A phase II trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian, primary peritoneal serous cancer, or fallopian tube cancer.
Berkenblit, Anna
A phase II trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian, primary peritoneal serous cancer, or fallopian tube cancer. [electronic resource] - Gynecologic oncology Dec 2004 - 624-31 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
0090-8258
10.1016/j.ygyno.2004.08.028 doi
Aged
Antineoplastic Agents, Phytogenic--administration & dosage
Cystadenocarcinoma, Serous--drug therapy
Docetaxel
Drug Administration Schedule
Drug Resistance, Neoplasm
Fallopian Tube Neoplasms--drug therapy
Female
Humans
Middle Aged
Organoplatinum Compounds--therapeutic use
Ovarian Neoplasms--drug therapy
Peritoneal Neoplasms--drug therapy
Taxoids--administration & dosage
A phase II trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian, primary peritoneal serous cancer, or fallopian tube cancer. [electronic resource] - Gynecologic oncology Dec 2004 - 624-31 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
0090-8258
10.1016/j.ygyno.2004.08.028 doi
Aged
Antineoplastic Agents, Phytogenic--administration & dosage
Cystadenocarcinoma, Serous--drug therapy
Docetaxel
Drug Administration Schedule
Drug Resistance, Neoplasm
Fallopian Tube Neoplasms--drug therapy
Female
Humans
Middle Aged
Organoplatinum Compounds--therapeutic use
Ovarian Neoplasms--drug therapy
Peritoneal Neoplasms--drug therapy
Taxoids--administration & dosage